Key facts
- BrainSightAI’s last known valuation is $19.1M (Jan 2025).
- It has raised $6.6M; the latest was Later Stage VC ($5.0M) in Jan 2025.
- Notable investors include Google for Startups, MedTech Innovator, Entrepreneurs First, Indian Angel Network, ACV Capital — 33 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 33 names
- ·Watchlist + deal alerts for BrainSightAI
- ·The full record, as it builds
Funding rounds
No funding rounds for BrainSightAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrainSightAI
Developer of visualization tools designed to investigate the structural and functional patterns of the brain. The company's artificial intelligence-powered software tool provides imaging biomarkers to identify and classify disorders such as schizophrenia, bipolar disorder, and dementia, enabling psychiatrists to diagnose patients accurately and with speed.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2019
- Employees
- 43
- Website
- brainsightai.com/
- Ownership
- Privately Held (backing)
BrainSightAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrainSightAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrainSightAI in its N-PORT filings yet. We sweep new filings monthly.